| Paul Garvin | Chairman to 31stJanuary 2021 |
|||||||
|---|---|---|---|---|---|---|---|---|
| Neil Mundy | Interim Joint Chairman from 1stFebruary 2021 tc31stJuly 2021 |
|||||||
| Derek Bell | Joint Chairman from 1st September 2021 |
|||||||
| Julia Ann Gillon | Chief Executive | |||||||
| Anandapuram | Deepak Dwarakanath | Medical Director /Deputy Chief Executive |
||||||
| Alan Sheppard | Chief People Officer | |||||||
| Neil Atkinson | Director ofFinance | |||||||
| Julie Lane | Director ofNursing, Patient Safety |
and Quality | to30th | November | 2020 | |||
| Graham Evens Lynne Taylor |
Chief Information Technology Offfcer Director of Planning 6 Performance |
|||||||
| Barbara Bright | Director ofCorporate Affairs and Chief ofStaff | |||||||
| Levi Buckley | Chief Operating Officer |
|||||||
| Stephen Hall |
Vice Chairman and Non-executive |
Director | ||||||
| Rita Taylor | Non-executive Director |
|||||||
| Jonathan Erskine |
Non-executive Director |
|||||||
| Kevin Robinson | Non-executive Director |
|||||||
| Philip Craig | Nonwxecutive Director |
|||||||
| Ann Baxter | Associate Non-executive Director |
|||||||
| Neil Schneider | Associate Non-executive Director |
|||||||
| Undsey Robertson | Director of Nursing, Paffent Safety |
and Quality | from 1st September | 2020 | ||||
| The Executive | Directors | and Non-executive Directors ofthe Foundation Trust Board are |
the Trustee ofthe Charity. | |||||
| The Executive | Directors | are appointed | by the Non-executive Directors |
and the Governors | appoint | the | Non- | |
| executive Directors. |
| ~E* | cht | coo | |||
|---|---|---|---|---|---|
| Lucera Bronchoscope | 27 | ||||
| Mini Probe | 5 | ||||
| Oefibriltator | 6 | ||||
| Motomed Muvi active Exercise plus |
7 | ||||
| Innaspire deluxe reusable sidestream |
& kit | 5 | |||
| MSK Ultrasound | system | 17 | |||
| Accuvein | 5 | ||||
| Fluent System | 27 | ||||
| Hysterscope | 25 | ||||
| Other medical equipment | |||||
| 143 |
| ajor refurbishments | and IT equipm | ent purchases during the year ar |
e shown below: |
|
|---|---|---|---|---|
| ~EDD | EDDD | |||
| Vocera volunteers | communication | badges and chargers | 9 | |
| 48x Dementia Touch screen tablets |
12 | |||
| LED Ceiling Mural | 8 | |||
| Other refurbishment | costs | |||
| 38 |
| erate | d char |
itable fun | ds in | come will support patient car |
e and benefits, staff health and wellbeing. |
|---|---|---|---|---|---|
| ~EditlEOOD | |||||
| Staff | loNeiy | winnings | paid | ||
| Staff | loNery | administration | costs | ||
| 12 |
| Statement of Financia | l Ac | tivities for the y | ear ended | 31 March 2021 | |||
|---|---|---|---|---|---|---|---|
| Total | Total | ||||||
| Note | Unrestricted | Reslrlrsed | Funds | Funds | |||
| Funds | Funds | 2020/21 | 2019/2D | ||||
| f000 | f000 | f000 | fOOD | ||||
| Income and endowments | from: | ||||||
| Donations | 3 | 440 | 107 | 547 | 341 | ||
| Legacies | 3 | 16 | 16 | 118 | |||
| Charitable activities |
4 | 20 | 20 | 15 | |||
| Other trading activities-staff | lottery | 5 | 17 | 17 | |||
| Other incoming resources |
6 | 61 | 5 | 66 | 100 | ||
| Investment Income |
13.3 | 14 | 26 | 40 | 39 | ||
| Total incoming resources | 515 | 191 | 706 | 6'I3 | |||
| Expenditure on: |
|||||||
| Raising Funds | 12 | 12 | |||||
| Charitable activities: |
|||||||
| Research Posts and Clinical | Care | 29 | 29 | 72 | |||
| Purchase ofEquipment | 69 | 74 | 143 | 60 | |||
| Refurbishment costs |
9 | 29 | 38 | 80 | |||
| Stafl Education and Welfare |
160 | 18 | 178 | 62 | |||
| Patient Welfare | 1 | 9 | 10 | 37 | |||
| Governance Costs |
10 | 13 | 24 | 37 | 35 | ||
| Total expenditure Net gain/(losses) on investments |
13.1 | 252 84 |
195 149 |
233 | ~3 | ||
| Net income/(expenditure) | before transfers | 347 | 145 | 492 | 230 | ||
| Transfers between funds |
16 | 2 | (2) | ||||
| Net movement in funds |
18 | 349 | 143 | 492 | 23D | ||
| Fund balances brought |
forward at 1 April | 1,087 | 1,554 | 1,324 | |||
| Fund balances carried | forward at 31 March | 816 | 1,23D | 2,046 | 1,554 |
| Note | Unrestricted | Restricted | Total at31 | Total at 31 | ||
|---|---|---|---|---|---|---|
| Funds | Funds | March 2021 | March 2020 | |||
| FOOD | 5000 | 8000 | 8000 | |||
| Fixed Assets | ||||||
| Investments | 13 | 551 | BDO | 1,351 | 1 113 | |
| Total fixed assets | 551 | 800 | 1,351 | 1,118 | ||
| Current Assets | ||||||
| Debtors and accrued income | 14 | 250 | 30 | 280 | 14 | |
| Cash and cash equivalents | 67 | 453 | 520 | 455 | ||
| Total current assets | 317 | 483 | 800 | 469 | ||
| Current liabilities |
||||||
| Creditors: Amounts | falling due | |||||
| within one year | 15 | 52 | 53 | 105 | 33 | |
| Net current assets | 265 | 430 | 695 | 436 | ||
| Total assets less current liabilities | 816 | 1,230 | 2,046 | 1,554 | ||
| Net Assets | 816 | 1,230 | 2,046 | 1,554 | ||
| The funds ofthe charity | ||||||
| Restricted income funds |
1,230 | 1,230 | 1,087 | |||
| Unrestricted income |
funds | 816 | 816 | 467 | ||
| Total Charity Funds | 19 | 816 | 1,230 | 2,046 | 1,554 |
| Note | |||||||
|---|---|---|---|---|---|---|---|
| 2020I21 | 2019I20 | ||||||
| 2000 | 5000 | ||||||
| Cash flows from operating | activities: | ||||||
| Net cash used in operating | acflvifles | 18 | 25 | 222 | |||
| Cash flows from investing | activities: | ||||||
| Dividends | and interest from | investments | 13.3 | 40 | 39 | ||
| Proceeds | from sale of investments | ||||||
| Net cash | provided by investing activities |
40 | 39 | ||||
| Change | in cash and cash | equivalents | in the reporting | period | 65 | 261 | |
| Increase | in cash and cash equivalents | in lhe year | 65 | 261 | |||
| Cash and | cash equivalents | at the beginning | of | ||||
| reporting | period | 455 | 194 | ||||
| Total cash and cash equivalents at the end |
520 | 455 | |||||
| ofthe year |
| Payments | to | Receilpts from | Receilpts from | Amounts | owed | Amounts | due | ||
|---|---|---|---|---|---|---|---|---|---|
| related parties | related | parties | to related | parties | from related | ||||
| parties | |||||||||
| EOOO | f000 | f000 | FOOD | ||||||
| Declaration of Interest | |||||||||
| 2020/21 | |||||||||
| Optimus | Health | Ltd | 250 | ||||||
| NTH Solutions | LLP | ||||||||
| 2019/20 | |||||||||
| Optimus | Health | Ltd | 175 | ||||||
| NTH Solutions | LLP | ||||||||
| Optimus | Health | Ltd | |||||||
| (Trading | Company | for North Tees and Harilepool | NHS | Foundation | Trust) |
| Unrestricted | Restricted | Total | Total | |||
|---|---|---|---|---|---|---|
| Funds | Funds | 2020/21 | 2019/20 | |||
| ROOD | FOOD | RDOO | RODO | |||
| Donations | 2 | 79 | 81 | 135 | ||
| Fundraising | Income Generated | by Donors | 11 | 19 | 30 | 8 |
| Grants Receivable | 173 | 173 | ||||
| Corporate | Donations | 250 | 7 | 257 | 194 | |
| GIR Aid | 4 | 2 | 6 | 4 | ||
| Legacies | 16 | 16 | 1'I8 | |||
| Total | 123 | 663 |
| The income | was pri | marily from the prov |
ision oftraining courses | in furtherance oft |
he Charity's obje |
ctives. |
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2020/21 | 2019/20 | |||
| FOOD | ROOD | ROOD | RDDD | |||
| Income from | the provision | |||||
| ofeducation | and training | 20 | 20 | 15 | ||
| Total | 20 | 20 | 15 | |||
| 5.Other Trading Activities | ||||||
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2020/21 | 2019/20 | |||
| FOOD | FOOD | ROOD | ROOD | |||
| Staff Lotlery | deductions | 17 | 17 | |||
| Total | 17 | 17 | ||||
| 6. Other incoming | Resources | |||||
| Unrestricted | Restricted | Total | Total | |||
| Funds | Funds | 2020/21 | 2019/20 | |||
| ROOD | ROOD | FOOD | FODO | |||
| Other Income | 61 | 5 | 66 | 100 | ||
| Total | 61 | 5 | 66 | 100 |
| 2020/21 | 2019/20 | ||||
|---|---|---|---|---|---|
| EOOO | EOOO | ||||
| Staff | Lottery | Winnings | &Admin | 12 | |
| Total | 12 |
| 2020/21 | 2019/20 | ||
|---|---|---|---|
| EOOO | EOOO | ||
| Purchase of Equipment | 143 | 60 | |
| Research Posts | and Clinical Care | 29 | 72 |
| Refurbishment Costs & IT Equipment |
38 | 80 | |
| Staff Education | and Welfare | 178 | 62 |
| Patients Welfare | 10 | 37 | |
| Total | 398 | 311 |
| The investment is v |
The investment is v |
alued at bid | alued at bid | alued at bid | price 2020/21. | ||
|---|---|---|---|---|---|---|---|
| 13.1 Movement In |
fixed asset | investment | 2020/21 | 2019/20 | |||
| Total | Total | ||||||
| 6000 | 8000 | ||||||
| Market value | brought | forward | 1,118 | 1,155 | |||
| Monies owed | by CCLA for | Charities | 10 | 10 | |||
| Short tenn dividends | (10) | (10) | |||||
| Less disposals at carrying | value | ||||||
| Net (loss)/gain | on revaluation | 233 | |||||
| Market value | at 31 | March | 1,351 | 1,118 | |||
| 13.2 Market value at | 31 March | 2020/21 | 2019/2D | ||||
| Total | Total | ||||||
| 8000 | F.ODD | ||||||
| Held In UK | |||||||
| COIF Charities Investment |
Fund | 1,351 | 1,118 | ||||
| Total | 1,351 | 1,118 | |||||
| The COIF Charities | Investment | Fund includes the following | investments: | ||||
| 2020/21 | 2019/20 | ||||||
| Asset allocation | |||||||
| Ovemeas Equities |
67.23% | 80.21% | |||||
| UK Equities | 9.S9% | 12.60% | |||||
| Infrastructure | &Operating | Assets | 9.12% | 968% | |||
| Cash &near cash | 4.83% | 620% | |||||
| Property | 3.90% | 5.37% | |||||
| Contractual 8 |
Other | Income | 268% | 3.25% | |||
| Private Equity | 8 Other | 2.01% | 2.15% | ||||
| Fixed Interest | 0.34% | 0.54% |
| 13.3 Total gross Income from inves | tments and cash on deposit |
|
|---|---|---|
| 2020/21 | 2019/20 | |
| Total | Total | |
| EOOO | EOOO | |
| Held in UK | ||
| Investments | 39 | |
| Total | 40 | 39 |
| Debtors | under | one | year | 2020/21 | 2019/20 |
|---|---|---|---|---|---|
| Total | Total | ||||
| f000 | EOOO | ||||
| Dividend | Income | 10 | 10 | ||
| Prepayments | 4 | 4 | |||
| Accrued | Income | 266 | |||
| Total | 260 | 14 |
| Creditors | under one year | under one year | 2020/21 | 2020/21 | 2019/20 | |
|---|---|---|---|---|---|---|
| Total | Total | |||||
| EOOO | E000 | |||||
| Accruals | 64 | 'I9 | ||||
| Deferred | Income | 9 | 9 | |||
| Amounts | owed | to North Tees and | Hartlepool | NHS | 32 | 5 |
| Foundation Trust |
||||||
| Total | 105 | |||||
| There is no security for non-trading | amounts | owed to the Foundation | Trust. | |||
| 16. Transfers | between funds | 2020/21 | 2019/20 | |||
| Total | Total | |||||
| f000 | EOOO | |||||
| Transfers |
| 2020/21 | 2019/20 | ||||
|---|---|---|---|---|---|
| Total | Total | ||||
| 5000 | 5000 | ||||
| Net movement in funds |
492 | 230 | |||
| (Gain)/Loss on investments |
(233) | 37 | |||
| Deduct interest/dividends | income shown | ||||
| in investing activities |
(40) | (39) | |||
| (Increase)/ Decrease | in debtors | (266) | (3) | ||
| Increase/(Decrease) | in creditors | 72 | (3) | ||
| Net cash generated | from | operating | activities | 25 | 222 |
| 19.Analysis o | fC | hadta | bl | e Funds |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund Balances | Incoming | Resources | Internal | Fund Balances | ||||||||
| at 31March 2020 | Resources | Expended | Transfers | al 31March 2021 | ||||||||
| flame | Deva//pr/cn ofthe nature end purpose |
cfthe fund | &000 | 2000 | &000 | ROOD | EDOO | |||||
| OVER &25,000 | OVER &25,000 | |||||||||||
| To support patient cere within the Directorate of |
||||||||||||
| t Memorial Fund |
(Surgery | ) | Surgery | 45 | 51 | |||||||
| To support patient care within breast | service | |||||||||||
| 2 Breast Surgery | Fund | Indudlng equipmenl &training |
62 | 75 | ||||||||
| To support patient care for individuals | requiring | |||||||||||
| 9 Spinal Fund | treabnent vnthln the Spinal Deparlmenl |
47 | 48 | |||||||||
| To support patient care fcr individuals |
with blood | |||||||||||
| 4 Haematclogy Fund |
disorders | 113 | 21 | (10) | 124 | |||||||
| To support patlenl care for individuals |
diagnosed | |||||||||||
| 5 Urofogy Research Fund | with Urology/Kidney refsted IUness |
33 | 38 | |||||||||
| a M Legacy Fund | To support the purchase ofequipment benefit ofcancer patients |
for the | 162 | 43 | (52) | 153 | ||||||
| To supped patient cere for Individuals |
requirfng | |||||||||||
| 7 Cardiology Fund 9 Neo-Natal |
treatment within the Cardiac unit Tosupport patient care for Individuals Ireatmenl within the neo.natal unit |
requiring | 1DO 32 |
19 | (3) (9) |
116 28 |
||||||
| To support stroke patilenh welfare and |
staff | |||||||||||
| 9 Stroke Fund | training To support Colorectal patient services. |
staff | 37 | 16 | (10) | 43 | ||||||
| to Colorec!sl Cancer Fund | EducaUon &Training |
(4) | 30 | |||||||||
| 11 Neonatal Life Support |
Support running cfLlfe Suppcrl coume |
28 | 18 | (5) | 41 | |||||||
| Breast Cancer nurse training / Welfare |
& | |||||||||||
| r2 Sreast Care Nursing | Fund | hardship fund fcrpatients |
88 | |||||||||
| Tosupport patient care for Individuals |
requiring | |||||||||||
| ts Chemotherapy Fund |
treabnenlwUhln Chemotherapy Fund UHNT |
49 | 21 | (17) | 53 | |||||||
| Funds increased | toabove | 526,000as st 31Igarch 2021 | ||||||||||
| Removed funds | decreased | to below &25,DOD as at31&larch 2021 | ||||||||||
| Funds at 31 March 202'I | 771 | 217 | (122) | 866 | ||||||||
| Other Funds balances | less | than &25000ss al 31stMarch 2021 | 316 | 123 | (73) | (2) | ||||||
| Total Reslrl cled Funds | 1,097 | 34D | 196 | 2 | 1,230 | |||||||
| Totaf Unrestricted | Funds | 467 | 599 | (252) | 816 | |||||||
| Total Fund balances at 31 Ii/larch 2D21 | 1,654 | 939 | 447 | 2,046 | ||||||||
| fntemal Transfem | Movement between restrldad snd unrestricted |
funds |